Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (716)

1

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence : PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

2

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

enthalten in: The New England journal of medicine | 2024

von Powles, T. | Valderrama, B. | Gupta, S. | +122

3

First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma : a randomized phase 3 study

enthalten in: Nature medicine | 2024

von Li, J. | Chen, Z. | Bai, Y. | +29

4

The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury

enthalten in: Redox biology | 2024

von Mapuskar, K. | Pulliam, C. | Tomanek-Chalkley, A. | +11

5

Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin : a randomized phase III trial (SPARED Trial)

enthalten in: British journal of cancer | 2024

von Minatogawa, H. | Izawa, N. | Shimomura, K. | +27

6

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER) : survival endpoints at 5 years in an open-label, randomised, phase 3 study

enthalten in: The Lancet. Oncology | 2024

von Pfister, C. | Gravis, G. | Flechon, A. | +53

7

Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer : Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Tewari, K. | Colombo, N. | Monk, B. | +16

8

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585) : an interim analysis of the multicentre, double-blind, randomised phase 3 study

enthalten in: The Lancet. Oncology | 2024

von Shitara, K. | Rha, S. | Wyrwicz, L. | +22

9

Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer : Results From the CANOPY-A Double-Blind, Randomized Clinical Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Garon, E. | Lu, S. | Goto, Y. | +16

10

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Oaknin, A. | Gladieff, L. | Martínez-García, J. | +117

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[72]